Conversely, in patients with early-stage adenocarcinoma, the expression of the SFRP5 gene was significantly higher in tumour samples than in normal tissues, and the authors suggested the oncogenic role of SFRP5 in lung adenocarcinoma [55]. This evidence concerns the gene SFRP5 and lung adenocarcinoma.